In collaboration with all regions of the country and the founding company partners, NEXT can now present, as something quite unique, a NEXT Master CTA (Clinical Trial Agreement). The document makes it possible to shorten time significantly from the first contact between the company and the clinics to trial start-up.

The NEXT Master CTA (contract for clinical trials) is now fully implemented, and we expect it to shorten considerably the average time to conclude a CTA. With the Master CTA in hand, the legal matters of the agreement are in place. This means that it can be signed by the sponsor and the hospital department as soon as the budget is approved.

The NEXT CTA can be used at NEXT departments within the following hospitals:
Amager and Hvidovre Hospital, Aalborg University Hospital, Aarhus University Hospital, Bispebjerg and Frederiksberg Hospital, Herlev and Gentofte Hospital, Naestved Sygehus, Odense University Hospital, Rigshospitalet and Zealand University Hospital.

We recommend that the NEXT Master CTA is used as often as possible when closing clinical trial agreements with NEXT departments. If your company wants a NEXT CTA please contact Project Director Britta Smedegaard Andersen who will deliver the edible text (the legal wording cannot be altered).

Process guideline